Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Carter

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Pathology|January 1, 1985
In vivo activity of a new heparinoidP A Ockelford, C J Carter, J Hirsh
Blood|December 1, 1979
Decreased platelet thrombogenecity in association with increased platelet turnover and vascular damageM R Buchanan, C J Carter, J Hirsch
Blood|October 1, 1982
A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpuraJ G Kelton, P J Powers, C J Carter
Blood Reviews|December 1, 1988
Heparin therapy for venous thrombosis and pulmonary embolismG E Raskob, C J Carter, R D Hull
Thrombosis Research|February 15, 1984
Studies on the frequency of heparin-associated thrombocytopeniaP J Powers, J G Kelton, C J Carter
Neuroscience Letters|December 12, 1986
2-Oxo-[14C]glutarate is taken up by glutamatergic nerve terminals in the rat striatumC J Carter, M Savasta, D Fage, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Interactions of 5-hydroxytryptamine and gamma-aminobutyric acid with dopamineC J Pycock, R W Horton, C J Carter
Biochemical Society Transactions|February 1, 1979
Possible involvement of frontal-cortical catecholamine systems in the regulation of neurotransmitter mechanisms at sub-cortical sites in the rat brain [proceedings]C J Pycock, C J Carter, R W Kerwin
Infection and Immunity|November 18, 2000
Surface protein variation by expression site switching in the relapsing fever agent Borrelia hermsiiA G Barbour, C J Carter, C D Sohaskey
Molecular Microbiology|July 1, 1994
Activation of a vmp pseudogene in Borrelia hermsii: an alternate mechanism of antigenic variation during relapsing feverB I Restrepo, C J Carter, A G Barbour
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Pathology|January 1, 1985
In vivo activity of a new heparinoidP A Ockelford, C J Carter, J Hirsh
Blood|December 1, 1979
Decreased platelet thrombogenecity in association with increased platelet turnover and vascular damageM R Buchanan, C J Carter, J Hirsch
Blood|October 1, 1982
A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpuraJ G Kelton, P J Powers, C J Carter
Blood Reviews|December 1, 1988
Heparin therapy for venous thrombosis and pulmonary embolismG E Raskob, C J Carter, R D Hull
Thrombosis Research|February 15, 1984
Studies on the frequency of heparin-associated thrombocytopeniaP J Powers, J G Kelton, C J Carter
Neuroscience Letters|December 12, 1986
2-Oxo-[14C]glutarate is taken up by glutamatergic nerve terminals in the rat striatumC J Carter, M Savasta, D Fage, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Interactions of 5-hydroxytryptamine and gamma-aminobutyric acid with dopamineC J Pycock, R W Horton, C J Carter
Biochemical Society Transactions|February 1, 1979
Possible involvement of frontal-cortical catecholamine systems in the regulation of neurotransmitter mechanisms at sub-cortical sites in the rat brain [proceedings]C J Pycock, C J Carter, R W Kerwin
Infection and Immunity|November 18, 2000
Surface protein variation by expression site switching in the relapsing fever agent Borrelia hermsiiA G Barbour, C J Carter, C D Sohaskey
Molecular Microbiology|July 1, 1994
Activation of a vmp pseudogene in Borrelia hermsii: an alternate mechanism of antigenic variation during relapsing feverB I Restrepo, C J Carter, A G Barbour
Pageof 15